Clinical trials recruiting for Portal Vein Thrombosis

Phase breakdown

Drugs and treatments being studied

Self-screener

Recruiting trials

• Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
  NCT07521332 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD
  NCT07461532 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS
  NCT07461545 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Freiburg TIPS Registry
  NCT05782556 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Indicators Affecting PVT Recanalization
  NCT07473375 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Portal Vein Thrombosis often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Portal Vein Thrombosis trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.